Viatris Inc (VTRS)
13.37
+0.12
(+0.91%)
USD |
NASDAQ |
Nov 22, 16:00
13.38
0.00 (0.00%)
After-Hours: 20:00
Viatris Cash from Investing (Quarterly): 1.748B for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 1.748B |
| June 30, 2024 | 375.80M |
| March 31, 2024 | -154.30M |
| December 31, 2023 | 127.10M |
| September 30, 2023 | -54.90M |
| June 30, 2023 | -86.80M |
| March 31, 2023 | -749.50M |
| December 31, 2022 | 1.784B |
| September 30, 2022 | -115.00M |
| June 30, 2022 | -82.10M |
| March 31, 2022 | -66.90M |
| December 31, 2021 | -219.10M |
| September 30, 2021 | -118.20M |
| June 30, 2021 | -16.80M |
| March 31, 2021 | 236.30M |
| December 31, 2020 | -22.30M |
| September 30, 2020 | -58.70M |
| June 30, 2020 | -74.50M |
| March 31, 2020 | -145.60M |
| December 31, 2019 | -114.50M |
| September 30, 2019 | -176.90M |
| June 30, 2019 | -158.40M |
| March 31, 2019 | -75.60M |
| December 31, 2018 | -175.60M |
| September 30, 2018 | -302.10M |
| Date | Value |
|---|---|
| June 30, 2018 | -303.80M |
| March 31, 2018 | -428.90M |
| December 31, 2017 | -220.70M |
| September 30, 2017 | -126.90M |
| June 30, 2017 | -452.00M |
| March 31, 2017 | -176.80M |
| December 31, 2016 | -596.20M |
| September 30, 2016 | -5.780B |
| June 30, 2016 | -1.141B |
| March 31, 2016 | -160.00M |
| December 31, 2015 | -930.40M |
| September 30, 2015 | -371.50M |
| June 30, 2015 | -180.30M |
| March 31, 2015 | -87.50M |
| December 31, 2014 | -83.40M |
| September 30, 2014 | -397.60M |
| June 30, 2014 | -118.10M |
| March 31, 2014 | -201.20M |
| December 31, 2013 | -1.506B |
| September 30, 2013 | -132.00M |
| June 30, 2013 | -88.90M |
| March 31, 2013 | -142.30M |
| December 31, 2012 | -146.37M |
| September 30, 2012 | -51.94M |
| June 30, 2012 | -57.66M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-749.50M
Minimum
Mar 2023
1.784B
Maximum
Dec 2022
109.62M
Average
-70.70M
Median
Cash from Investing (Quarterly) Benchmarks
| Lexicon Pharmaceuticals Inc | 53.47M |
| Moderna Inc | 721.00M |
| Baxter International Inc | -164.00M |
| Gilead Sciences Inc | -710.00M |
| Perspective Therapeutics Inc | -29.74M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 826.50M |
| Cash from Financing (Quarterly) | -1.637B |
| Free Cash Flow | 1.893B |
| Free Cash Flow Per Share (Quarterly) | 0.6174 |
| Free Cash Flow to Equity (Quarterly) | 2.090B |
| Free Cash Flow to Firm (Quarterly) | 893.62M |
| Free Cash Flow Yield | 11.77% |